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Abstract 
 
IL-1 is a central regulator of the immune response to acute brain injury.  IL-1α and IL-1β 
are the best-characterized cytokines of this family and signal through IL-1 receptor (IL-1RI). An 
understanding of the contribution of individual IL-1 pathway molecules following TBI is lacking 
and is of vital importance in developing potential anti-IL-1 therapies. We use lateral fluid 
percussion injury adapted to mice targeting moderate-severe TBI. C57BL6J and global IL-1 KO 
mice (on C57BL6J background) were used.  Gene expression was evaluated by qPCR. Barnes 
maze testing was used to evaluate cognitive function 2 weeks post-TBI. FPI resulted in increased 
inflammatory cytokine expression (IL-1α, IL-1β, TNF and IL-6) in both focal (left parietal 
cortex, hippocampus) and remote regions (brainstem, cerebellum).  At 6 hours, IL-1RI ablation 
decreased the spread of IL-1β and IL-6 expression to remote regions (brainstem, cerebellum).  At 
24hrs, IL-1RI ablation improved resolution of IL-1β and IL-6 in both focal (parietal cortex) and 
remote (brainstem) regions. Compared to WT littermates, IL-1RI KO mice performed better in 
the Barnes maze probe trial whereas IL-1α and IL-1β KO mice showed no significant 
improvement. Conclusions: FPI results in a diffuse inflammatory response with increased 
expression of pro-inflammatory cytokines at the injury epicenter, and in areas remote from 
impact. Combined, but not individual IL-1α and IL-1β blockade, prevented spread and hastened 
resolution of inflammatory cytokine expression. Furthermore, ablation of IL-1α or IL-1β alone 
was insufficient for cognitive protection following TBI, whereas combined blockade via IL-1RI 
ablation did result in cognitive rescue. Pharmacologic IL-1RI blockade appears to be a superior 
therapeutic strategy over individual IL-1 molecule blockade following TBI. 
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Introduction 
 Traumatic brain injury (TBI) is the leading cause of death and disability in children and 
young adults. According to the Centers for Disease Control and Prevention, an estimated 1.7 
million people per year sustain a TBI, of which approximately 50,000 die. The causes of TBI are 
extremely diverse ranging from abusive head trauma, commonly seen in infants, to motor vehicle 
collisions to the repetitive head injury frequently associated with contact sports. This diversity, 
however, is not reflected in the treatment protocols available to clinicians. Despite advances in 
neurosurgical interventions and intensive care monitoring, each case is treated in a similar 
fashion. Current treatment is largely supportive with no existing targeted pharmacologic 
therapies available, leaving many of the survivors left with permanent disability (Langlois et al., 
2006). In the U.S., an estimated 3 million people live with TBI-related disability. This highlights 
the critical need for targeted neuroprotective therapies. In addition to the devastating effect of 
TBI on survivors and their loved ones, there is a large societal cost produced by TBI including 
both direct medical and productivity costs. The annual cost of TBI is greater than 60 million 
dollars, making TBI the most costly kind of trauma (Faul et al., 2015).   
 TBI consists of a primary injury and secondary injury. The primary injury results from 
the initial impact of mechanical forces. This initial disruption in tissue occurs at the moment of 
insult and includes axonal shearing, contusion laceration and necrotic cellular death. The primary 
injury is followed by a secondary injury cascade that begins minutes after injury and can persist 
for days to months after the acute injury. The secondary injury cascade consists of excitotoxicity, 
oxidative stress, energy failure, and inflammation all of which compound the initial tissue insult, 
resulting in ongoing cell death and dysfunction. Neuroinflammation is the focus of our study and 
includes the activation of the Interleukin 1 (IL-1) cytokine pathway (Blennow et al., 2012). IL-1α 
and IL-1β are the two most recognized ligands in this pathway and signal through a common 
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receptor, type I IL-1 receptor (IL-1RI). IL-1β has been reported to rapidly increase after TBI and 
sustain increased expression for up to a year following TBI, and is known to play a potent role in 
the evolution and persistence of inflammation (Lu et al., 2005), (Hutchinson et al., 2007). The 
relative contribution of IL-1β to neurotoxicity is unknown as it has been implicated in both 
reparative and harmful effects after TBI (Rider et al., 2011). IL-1α is also rapidly upregulated 
following TBI, and its specific contribution to neuroinflammation is not yet known (Griffin et 
al., 1994). IL-1RI expression occurs on a variety on cell types including invading immune cells, 
endothelial cells, astrocytes, microglia, and neurons. In other neurologic disease models both 
CNS and hematopoietic IL-1RI signaling contributed to neuroinflammation and neurotoxicity, 
but this has never been dissected in TBI (McCandless et al., 2009). Additionally, results from 
other CNS injury models indicated that in ischemic brain injury, blockade of both IL-1α and IL-
1β provided the greatest neuroprotection, and in spinal cord injury, only IL-1α blockade resulted 
in improved function (Bastien et al., 2015), (Boutin et al., 2001).These differential roles of IL-1α 
and IL-1β have not yet been determined in TBI. 
 We aim to characterize the murine IL-1 response to experimental TBI using the lateral 
fluid percussion injury (FPI) model. FPI is a validated mouse model of TBI where mice first 
undergo a craniectomy; a small piece of the skull is surgically removed and a Luer-hoc hub is 
glued over the craniectomy site. The next day, mice are attached to an FPI device that delivers a 
pressurized fluid pulse against the exposed dura. Our model of injury is performed in adult mice, 
and is analogous to a moderate TBI injury sustained from a single impact, similar to the injury 
one might sustain in a motor vehicle accident or other moderate impact injuries. Using this 
model we aim to isolate the role of each IL-1 pathway molecule to TBI pathogenesis through use 
the use of three different IL-1knockout lines; IL-1α, IL-β, and IL-1RI global knockout mice. We 
hypothesize that IL-1α, IL-β, and IL-1RI will have different roles in injury-induced inflammation 
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and will contribute differently to TBI outcome. Understanding the individual contributions of 
each IL-1 molecule will be crucial to developing optimal strategies of therapeutic blockade. 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 
 
 
4	
	
Materials and Methods 
Animals 
 IL-1α -/-, IL-1β -/-, and IL-1R1 -/- global knockout mice were generated as previously 
reported (Ferguson et al., 2006). All animal procedures were performed in accordance with 
University of Iowa Institutional Animal Care and Use Committee guidelines. 
Fluid Percussion Injury: 
 8-16 week old mice underwent FPI or sham injury. A circular left parietal craniectomy 
lateral to the sagittal suture and centered between bregma and lambda was completed one day 
prior to TBI using a hand-held 3mm OD trephine drill. A Luer-loc hub was secured to the skull 
around the craniectomy site with dental acrylic, and filled with saline. Mice were allowed to 
recover overnight. On the following day mice were anesthetized with 3% isoflurane, and 
attached to the FPI device by the Luer-loc hub. The FPI device consisted of a hammer on a 
pendulum, dropped from a 11-12º angle to contact a plunger at the end of a fluid filled cylinder, 
creating a brief pulse of approximately 1.2-1.5 atm against the exposed dura, measured by a 
Tektronix digital oscilloscope (TDS460A). FPI injuries were delivered when animals’ responses 
indicated they were at a level III-1 anesthesia. Mice were disconnected from the device and 
underwent acute neurologic assessment by measuring the time to right, after which they were re-
anesthetized with isoflurane, the Luer-loc hub was removed and skin was sutured closed over the 
craniectomy and injury site. Mice receiving sham surgeries underwent identical surgical 
preparation, craniectomies, and connection to the FPI device. Then, the sham mice were 
disconnected without injury. Pressure data measured by the oscilloscope is validated by using 
righting reflex, a biologic variable shown to correlate with histopathologic damage, to confirm 
consistent level of injury. 
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Real Time PCR 
 Total RNA was extracted from snap frozen sham or FPI brain tissue 6 or 24 hours post 
FPI using TRIzol (Invitrogen) as per the manufacturer’s recommendations. RNA yield and purity 
were evaluated by absorbance readings at 260 and 280nm. First-strand cDNA was synthesized 
with SuperScriptIII reverse transcriptase (Invitrogen). Amplified cDNAs were diluted 1:15 in 
ultrapure water and subjected to real time PCR on an Applied Biosystems Model 7900HT with 
Taqman Universal PCR Mastermix (Applied Biosystems), and the following probes: IL-1β 
(Mm00434228_m1), IL-1α (Mm00439620_m1), IL-6 (Mm00446190_m1), TNF-α 
(Mm00443258_m1), GAPDH (4308313).The PCR reactions were carried out as follows: 2 min 
at 50 °C, 10 min at 95 °C, followed by 40 cycles for amplification at 95 °C for 15 s, 60 °C for 
60s. Genes of interest were normalized to GAPDH. 
Weight Data 
 Weight was monitored daily beginning on the day of FPI and continued through post 
injury day 3. Percent weight loss was quantified in comparison to baseline weight obtained at the 
time of craniectomy, which occurs one day before injury.  
Rotarod 
 Motor function was assessed using Rotamex. Each mouse was trained prior to sham or 
TBI for four days (3 trials/day with a 15min intertrial interval) where the speed of the rotor was 
accelerated from 4 to 40 RPM with an acceleration of 1.2 rpm/10sec. The average latency to fall 
was recorded and the highest pre-injury performance was used as baseline. Mice were then tested 
on post injury or sham days 1, 2, 3 and 7 using the test baseline settings. The average latency to 
fall was recorded and the percentage change from baseline performance was calculated. 
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Barnes Maze 
 As previously described cognitive function was assessed using the Barnes Maze. [5] The 
Barnes Maze consists of a circular table with 20 evenly spaced holes around the perimeter, and 4 
visual cues positioned around the table, Any Maze video tracking software was used for data 
collection. Two weeks following sham or FPI acquisition trials were conducted (4 trails/day) for 
4 days during which an escape box was placed under the target hole. Each trial ended when the 
mouse entered the target hole or after 80 seconds had elapsed, mice that did not locate the escape 
were guided to the target hole. All mice were allowed to remain in the escape box for 20 
seconds. Average latency to the escape hole was recorded for each acquisition day.  
 During the probe trial, conducted 1 day after the last acquisition trial, hippocampal 
dependent memory was assessed. The escape box was removed from under the target hole and 
the mice were placed in the maze for 60 seconds. Each mouse received 1 trial during which their 
head time in a 2cm diameter around the target hole was recorded. 
 
Table 1. A timeline breakdown of the experimental design. Inflammatory gene expression is 
quantified first followed by functional assessments. 
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Results and Discussion 
 The effect of IL-1α and IL-1β genetic blockade on early neuroinflammation was evaluated 
by quantitative PCR at 6 hours post FPI. IL-1β, IL-1α, IL-6, and TNF-α are all proinflammatory  
cytokines that are known to be upregulated after TBI. Their gene expression was evaluated in sham,  
WT FPI, IL-1α -/- FPI and IL-1β -/- FPI in the contralateral parietal cortex (L PCX), contralateral  
 
Figure 1:The effect of IL-1α and IL-1β blockade on inflammatory gene expression compared to 
their wild-type FPI littermates or sham injured mice. Cytokine expression was compared in WT 
sham (n=3), WT FPI (n=5), and IL-1α -/- FPI (n=5), and IL-1β -/- FPI (n=5). Data presented as 
mean + SEM. One way ANOVA *p<0.05 compared to sham. #p<0.05 compared to WT FPI.  
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hippocampus (L Hip), and brainstem (BS); expression is reported as fold change relative to sham 
(Figure 1). IL-1α blockade failed to modify inflammatory gene expression at 6hrs post FPI 
(Figure 1: A-C). Although both FPI groups show significantly higher inflammatory cytokine 
gene expression when compared to the sham injured mice, Il-1α ablation had no significant 
difference compared to WT FPI. IL-1β blockade decreased IL-1α expression in both focal (L 
PCX) and remote regions (BS) of the brain at 6 hours post FPI. This result is particularly 
interesting given the absence of this IL-1α modification in IL-1RI -/- mice (Figure 2).  
 
   
Figure 2: Regional expression of inflammatory cytokines 6 hours after FPI in IL-1RI deficient 
mice. Cytokine expression was compared in WT sham (n=3), WT FPI (n=5), and IL-1RI -/- FPI 
(n=5). Data presented as mean + SEM. One way ANOVA. * p <0.05 compared to sham. # 
p<0.05 compared to IL-1RI FPI.  
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These data suggest that IL-1β modifies IL-1α through an IL-1RI independent pathway, further 
work is needed to more clearly dissect the impact of the IL-1α decrease, and the mechanism by 
which IL-1β modifies IL-1α gene expression.  
 Compared to IL-1α or IL-1β deficiency, IL-1RI deficiency had the greatest impact on 
acute cytokine expression. At 6 hrs, IL-1RI -/- FPI mice showed decreased IL-1β and IL-6 gene 
expression in remote brain regions (brainstem and contralateral cerebellum (LCB)) compared to 
WT FPI littermates (Figure 2). Due to decreased inflammatory gene expression in only remote 
brain regions it is likely that IL-1RI deficiency prevents the spread of IL-1β and IL-6 from the 
impact site (contralateral cortex and hippocampus) to the brainstem and cerebellum. By 24 hours 
post FPI, Il-1RI deficiency resulted in decreased IL-1β and IL-6 expression in both the 
contralateral parietal cortex and the brainstem. This reduction in inflammatory gene expression 
in both focal and remote brain regions suggests that IL-1RI ablation hastens the resolution of 
both Il-1β and IL-6. 
 
Figure 3: Regional cytokine expression 24 hours following FPI in IL-1RI deficient mice. 
Cytokine expression compared in WT sham (n=3), WT FPI (n=6), and IL-1RI FPI (n=6). Data 
presented as mean + SEM. One way ANOVA. * p<0.05 compared to sham # p<0.05 compared 
to IL-1RI FPI.  
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 The rotarod assay was used to quantify motor function at days 1,2,3 and 7 post FPI. All 
injured mice had a decrease in motor function on days 1,2, and 3 with improvement by day 7. IL-
1α -/- FPI, Il-1β -/- FPI, and IL-1RI -/- FPI did not show improved motor funciton compared to 
their wildtype littermate (Figure 4). This is likely due to the motor cortex’s close proximity to the 
epicenter of injury which sustains a large amount damage due to the primary injury thus 
modification of the neuroinflammatory secondary injury cascade does not show improvement.  
 
 As another early functional endpoint, percent weight loss was quantified in comparison to 
baseline weight obtained at time of craniectomy. IL-1RI deficiency, but not IL-1α or IL-1β 
deficiency, resulted in improved weight on days 2, 3, and 4 post FPI (Figure 5). Weight is a key 
indicator of overall health and recovery; as such it is indicative of the potential therapeutic 
quality of IL-1RI. The improvement in weight could also be related to the reduction of spread 
and hastened resolution of neuroinflammation post FPI. Further studies are required to confirm 
the exact mechanism of action behind the weight improvement. 
Figure 4: Motor function was assessed 
using the Rotarod assay. For each subject 
the average the latency to fall was 
normalized to the highest pretraining 
performance. *p< 0.05. 
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Figure 5: Percent weight loss quantified in comparison to baseline weight. Data are presented 
as mean + SEM. Two-way ANOVA with Fisher’s LSD for multiple comparisons. *p<0.05 WT 
sham compared to WT FPI, +p<0.05 KO sham compared to KO FPI, #p<0.05 KO FPI 
compared to WT FPI.  
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To assess TBI induced cognitive dysfunction, the same mice in Figure 5 underwent 
Barnes maze testing beginning 2 weeks post-injuty. There was no genotype difference in training  
 
Figure 6: Cognitive function, specifically learning and spatial memory was assessed using the 
Barnes Maze. Data are presented as mean + SEM. Acquisition training two-way RM ANOVA 
with Fisher’s LSD for multiple comparisons. *p<0.05 compared to WT sham. +p<0.05compared 
to KO sham. Probe trial one –way ANOVA with Fisher’s LSD for multiple comparisons. 
*p<0.05.  
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days 1-4; there was, however, a significant difference in the probe trial. IL-1RI -/- FPI mice 
showed significantly higher time in the escape zone during the probe trail (Figure 6). This result 
indicates that IL-1RI deficiency, but not IL-1α or IL-1β deficiency resulted in improved 
hippocampal dependent spatial memory post FPI.   
Conclusion 
These data show that FPI results in a diffus inflammatory response, with increased 
expression of pro-inflammatory cytokines at the injury epicenter and in remote regions. Acute 
inflammatory cytokine gene expression showed that IL-1RI deficiency, but not individual IL-1α 
or IL-1β blockade, prevented spread and hastened the resolution of IL-1β and IL-6 expression. 
IL-1RI deficiency also resulted in improved weight and memory post FPI, these improved 
functional outcomes were not observed in IL-1α -/- or IL-1β -/- FPI mice. These data suggests 
that for TBI, IL-1RI blockade is a superior therapeutic strategy over individual IL-1 molecule 
blockade.  
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